local_hospital

Wellbeing Services County Of North Karelia Siun Sote

Address
Tikkamaentie 16, 80210 Joensuu, Finland

Cardiovascular Diseases Research at Wellbeing Services County Of North Karelia Siun Sote

This Heart Center in Joensuu, Finland is focused on cardiovascular diseases, with studies centered on improving care for people at risk of serious heart and blood vessel events. The research landscape includes efforts to test new treatment strategies, refine prevention approaches, and support better outcomes in everyday clinical practice.

  • Research in coronary artery disease is evaluating whether device-based treatment options can offer effective care while better matching the needs of patients with a higher risk of bleeding.
  • Studies in acute myocardial infarction are exploring faster, more practical ways to respond to suspected heart attacks and improve early treatment effectiveness.
  • Trials in stroke prevention are assessing new approaches to reduce the risk of recurrent ischemic events after acute ischemic stroke or high-risk transient ischemic attack.

Across the site’s clinical trials, the common goal is to strengthen prevention and treatment for patients with high-risk cardiovascular conditions, while also examining safety and real-world usefulness of emerging therapies.

Site Overview

assignment
7
connected trials
corporate_fare
5
sponsors
science
8
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
5
Active sponsors
4

Sponsor Network

Top 4 by active trials.

lock +3 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 107 other sites in Finland

description
Trial volume
7
Outperforms 79% of sites
public
Therapeutic diversity
2areas
Outperforms 36% of sites
groups
Sponsor diversity
5sponsors
Outperforms 75% of sites

Therapeutic Area Benchmark — Finland

Select a therapeutic area to compare against other sites in Finland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Finland

Market Share

Country: Finland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Wellbeing Services County Of North Karelia Siun Sote

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative ColitisMerck Sharp & Dohme LLCPhase IIINot RecruitingAug 2024

IMP list

lock Showing 1 of 8 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Tulisokibart3Unknown2024-08-202025-09-29

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.